Showing results (701-710 of 1,195) with videos related to
Sort By:
Pageof 120
Biology of Reproduction|March 15, 2013
Gonadal expression of Foxo1, but not Foxo3, is conserved in diverse Mammalian speciesEdward D Tarnawa, Michael D Baker, Gina M Aloisio, et al.Minimally Invasive Neurosurgery : MIN|September 3, 2010
Transcorporeal tunnel approach for unilateral cervical radiculopathy: a 2-year follow-up review and resultsG Choi, N J Arbatti, H N Modi, et al.Journal of Spinal Disorders & Techniques|July 14, 2010
Risk of developing seizure after percutaneous endoscopic lumbar discectomyGun Choi, Ho-Yeong Kang, Hitesh N Modi, et al.American Journal of Public Health|December 1, 1991
Knowledge about HIV and behavioral risks of foreign-born Boston public school studentsR W Hingson, L Strunin, M Grady, et al.Critical Care Medicine|January 11, 2000
Paralysis in the critically ill: intermittent bolus pancuronium compared with continuous infusionJ M de Lemos, R R Carr, K F Shalansky, et al.Plos One|February 24, 2015
Mitochondrial genome sequencing and development of genetic markers for the detection of DNA of invasive bighead and silver carp (Hypophthalmichthys nobilis and H. molitrix) in environmental water samples from the United StatesHeather L Farrington, Christine E Edwards, Xin Guan, et al.The Journal of Clinical Endocrinology and Metabolism|April 1, 1995
Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center studyB R Carr, N A Breslau, C Givens, et al.Analytica Chimica Acta|May 14, 2013
Investigating the feasibility of mid infrared spectroscopy for monitoring an industrial de-racemization biotransformation processP Gardner, S A Arnold, F Brown, et al.Placenta|March 1, 1990
17 beta-hydroxysteroid oxidoreductases of human fetal and adult tissues: immunological cross-reactivity with an anti-human placental cytosolic 17 beta-hydroxysteroid oxidoreductase antibodyL Milewich, B R Carr, R A Frenkel, et al.Contraception|October 10, 2020
Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta®) discontinuationBruce R Carr, Michael A Thomas, Angelina Gangestad, et al.Pageof 120